# NUTEX HEALTH INC. (NUTX) FY2026 Q2 Balance Sheet

- Company: NUTEX HEALTH INC. (NUTX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001628280-26-054268
- Page: https://plicit.ai/financials/nutx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/nutx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 964,629,000 US dollars
- **Current assets**: 585,650,000 US dollars
- **Non-current assets**: 378,979,000 US dollars
- **Liabilities**: 457,317,000 US dollars
- **Current liabilities**: 117,220,000 US dollars
- **Non-current liabilities**: 340,097,000 US dollars
- **Equity**: 507,312,000 US dollars
- **Noncontrolling interest**: 112,996,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable - Nonrelated Party**: 351,675,000 US dollars
- **Cash and cash equivalents**: 205,208,000 US dollars
- **Prepaid expenses and other current assets**: 17,635,000 US dollars
- **Accounts receivable - Related Party**: 5,025,000 US dollars
- **Inventories**: 4,207,000 US dollars
- **Restricted cash**: 1,900,000 US dollars
- **Financing lease right-of-use assets**: 219,067,000 US dollars
- **Property and equipment, net (accumulated depreciation of 33,598 and 31,696 as of June 30, 2026 and December 31, 2025, respectively)**: 95,702,000 US dollars
- **Operating lease right-of-use assets**: 26,150,000 US dollars
- **Intangible assets, net**: 20,580,000 US dollars
- **Goodwill, net**: 13,919,000 US dollars
- **Other assets**: 3,561,000 US dollars
- **Accrued arbitration expenses**: 49,668,000 US dollars
- **Accrued expenses and other current liabilities**: 30,629,000 US dollars
- **Current portion of long-term debt**: 8,496,000 US dollars
- **Financing lease liabilities, current portion**: 7,271,000 US dollars
- **Accounts payable - Related Party**: 5,679,000 US dollars
- **Accrued stock-based compensation**: 4,854,000 US dollars
- **Accounts payable - Nonrelated Party**: 4,281,000 US dollars
- **Accrued income tax expense**: 4,006,000 US dollars
- **Operating lease liabilities, current portion**: 2,238,000 US dollars
- **Lines of credit**: 98,000 US dollars
- **Non-current financing lease liabilities, net**: 268,905,000 US dollars
- **Long-term debt, net**: 31,105,000 US dollars
- **Non-current operating lease liabilities, net**: 29,223,000 US dollars
- **Deferred tax liabilities**: 10,864,000 US dollars
- **Additional paid-in capital**: 567,847,000 US dollars
- **Common stock, $0.001 par value; 950,000,000 shares authorized; 6,951,622 and 5,511,452 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively**: 7,000 US dollars
- **Noncontrolling interests**: 112,996,000 US dollars
- **Accumulated deficit**: negative 173,538,000 US dollars
- **Gross equity (calculated)**: 680,850,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.